Previous 10 | Next 10 |
2023-07-29 18:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-07-27 06:00:52 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips While discrediting the acumen of experts seems to be a popular exercise on the Internet, investors can potentially gain handsomely from top analyst stocks. Of course, you’ll find some re...
BD Names Joanne Waldstreicher to Board of Directors PR Newswire FRANKLIN LAKES, N.J. , July 24, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Dr. Joanne Walds...
2023-07-24 12:51:24 ET Shares of Becton, Dickinson (NYSE: BDX) were up by more than 6% as of 12:15 p.m. ET Monday, after having climbed by as much as 8.5% shortly after 10 a.m. The medical equipment company announced Friday after the markets closed that the Food and Drug Administrat...
Becton, Dickinson And Company (NYSE: BDX) is one of today's top gainers. The company's shares are currently up 6.3% on the day to $281.53. Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare ins...
BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris™ Infusion System PR Newswire FRANKLIN LAKES, N.J. , July 24, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) Chairman, CEO and President Tom Polen issued the following mes...
2023-07-21 18:00:35 ET Summary Embecta Corp.'s stock has dropped 31% since its last publication, and analysis suggests this trend may continue. Despite securing key partnerships and signing multi-year agreements, projected revenue and earnings growth is flat. Net-net, reiterat...
BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System PR Newswire BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that includes large volume pumps, syringe pumps, patient-controlled an...
2023-07-20 12:30:04 ET Omnicell ( NASDAQ: OMCL ) traded lower on Thursday after Wells Fargo downgraded the pharmacy service provider to Underweight from Overweight, citing risks to the company’s year-to-date rally. The analyst Stan Berenshteyn argues that Omnicell ( OMC...
BD Issues FY 2022 ESG Report, Highlights Notable Progress in Energy and Waste Reduction, Health Care Access and Diversity PR Newswire Company Expands its ESG Focus Areas to Include Advancing Health Equity in Under-Resourced Communities FRANKLIN LAKES, N.J. , ...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...
BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023 PR Newswire FRANKLIN LAKES, N.J. , July 10 , 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has surpassed its Scope 1...